Omid Khalafi: PCT – The Platelet Parameter Almost Everyone Ignores
Omid Khalafi, Technical Support Specialist and After Sale Service Manager at Pharmateb, shared a post on LinkedIn:
“PCT (Plateletcrit): The Platelet Parameter Almost Everyone Ignores
Most clinicians routinely review Platelet Count (PLT) and occasionally MPV, but one parameter is frequently overlooked despite being automatically reported by many hematology analyzers:
Plateletcrit (PCT).
PCT represents the total circulating platelet mass, analogous to how hematocrit represents the volume occupied by red blood cells.
How is PCT calculated?
PCT (%) equals Platelet Count times MPV divided to 10,000
This means PCT reflects both:
- The number of platelets
- Their average size
As a result, two patients with identical platelet counts may have completely different platelet masses.
Why Does PCT Matter?
Looking at platelet count alone may be misleading.
For example:
Patient A
- Platelet Count: 180 ×10⁹/L
- MPV: 7.5 fL
Patient B
- Platelet Count: 180 ×10⁹/L
- MPV: 12.0 fL
Although both have the same platelet count, Patient B has a substantially higher circulating platelet mass.
PCT captures this important difference.
Clinical Applications
PCT has shown potential value in:
- Assessing platelet production and consumption
- Inflammatory diseases
- Cardiovascular disorders
- Monitoring thrombocytopenic patients
- Complementing MPV and PDW during platelet evaluation
It should never replace platelet count, but rather be interpreted together with other platelet indices.
Platelet Count tells you how many platelets are present.
MPV tells you how large they are.
PCT tells you how much platelet mass is actually circulating.
Using all three together provides a far more complete picture than relying on platelet count alone.”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments